ING3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.939100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.751400E-01
Normal-vs-Stage2
2.644300E-03
Normal-vs-Stage3
1.596970E-01
Normal-vs-Stage4
2.120600E-01
Stage1-vs-Stage2
9.983700E-02
Stage1-vs-Stage3
1.319380E-01
Stage1-vs-Stage4
6.531000E-01
Stage2-vs-Stage3
6.158900E-03
Stage2-vs-Stage4
5.792800E-01
Stage3-vs-Stage4
2.560200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.943100E-03
Normal-vs-AfricanAmerican
2.076800E-01
Normal-vs-Asian
6.924400E-03
Caucasian-vs-AfricanAmerican
4.434400E-01
Caucasian-vs-Asian
9.634500E-02
AfricanAmerican-vs-Asian
9.742100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.878100E-03
Normal-vs-Female
2.435600E-02
Male-vs-Female
1.384990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.200400E-01
Normal-vs-Age(41-60Yrs)
2.004000E-02
Normal-vs-Age(61-80Yrs)
5.398600E-03
Normal-vs-Age(81-100Yrs)
2.645700E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.362600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.261200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.025000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.289180E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.406400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.937000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.705600E-01
Normal-vs-Daily Drinker
1.873020E-01
Normal-vs-Weekly Drinker
2.206100E-02
Normal-vs-Occasional Drinker
1.638630E-01
Normal-vs-Social Drinker
7.202200E-02
Non Drinker-vs-Daily Drinker
5.830400E-01
Non Drinker-vs-Weekly Drinker
2.452200E-01
Non Drinker-vs-Occasional Drinker
9.460300E-02
Non Drinker-vs-Social Drinker
2.559800E-02
Daily Drinker-vs-Weekly Drinker
4.918400E-01
Daily Drinker-vs-Occasional Drinker
1.719420E-01
Daily Drinker-vs-Social Drinker
8.707600E-02
Weekly Drinker-vs-Occasional Drinker
4.494800E-01
Weekly Drinker-vs-Social Drinker
3.887400E-01
Occasional Drinker-vs-Social Drinker
9.546800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.696600E-01
Normal-vs-Grade 2
2.852800E-01
Normal-vs-Grade 3
3.893800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.171800E-01
Grade 1-vs-Grade 3
5.678000E-01
Grade 1-vs-Grade 4
3.696600E-01
Grade 2-vs-Grade 3
9.729200E-01
Grade 2-vs-Grade 4
2.852800E-01
Grade 3-vs-Grade 4
3.893800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.216000E-01
Normal-vs-NonDiabetic
2.939600E-03
Diabetic-vs-NonDiabetic
7.506200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.829810E-01
Normal-vs-NoPancreatitis
3.743800E-03
Pancreatitis-vs-NoPancreatitis
3.393200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.777900E-02
Normal-vs-N1
2.238000E-03
N0-vs-N1
3.431000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.036600E-01
Normal-vs-TP53-NonMutant
1.034590E-01
TP53-Mutant-vs-TP53-NonMutant
2.563000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
